StockData
INSMED Inc logo

INSMED Inc (INSM) bonds

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$121.86−1.02 (-0.83%)

Close on Nov 17, 2026Market cap $26.73BP/E –Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

Total debt
$555.09M
$10.23M due within a year
Net debt
$158.53M
After $396.56M of cash
Implied interest rate
10.19%
FY2025 interest ÷ average debt
Interest coverage
-14.9×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Insmed's 10-Q for the period ended Sep 30, 2026

IssueCouponMaturesAmount issuedCarrying value
0.75% Convertible Senior Notes Due 2028
Convertible at $33 a share
0.75%2028$567.50M–
Convertible notes
Convertible
–––$0

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
Royalty Financing Agreement interest expense$150.00M–
Term Loans$500.00M$544.86M
Tranche A Term Loan$350.00M–

See a number that looks wrong?